3SBio Inc. (OTCMKTS:TRSBF – Get Free Report) saw a significant increase in short interest during the month of April. As of April 30th, there was short interest totaling 395,582 shares, an increase of 646.4% from the April 15th total of 53,000 shares. Based on an average daily volume of 236 shares, the short-interest ratio is currently 1,676.2 days.
3SBio Stock Performance
3SBio stock opened at $2.85 on Thursday. 3SBio has a fifty-two week low of $2.22 and a fifty-two week high of $4.74. The firm’s 50-day simple moving average is $2.78 and its 200 day simple moving average is $3.18.
About 3SBio
3SBio Inc (OTCMKTS: TRSBF) is a China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of protein-based therapeutics and chemical drugs. Established in 1999 and headquartered in Shenyang, Liaoning Province, the company has built an integrated platform that encompasses in-house R&D capabilities, clinical development, commercial production and a nationwide sales network.
The company’s product portfolio features a range of hematopoietic growth factors such as recombinant human granulocyte colony-stimulating factor (rhG-CSF) and recombinant human erythropoietin (rhEPO), insulin and insulin analogs, hemostasis agents and monoclonal antibodies.
Featured Stories
- Five stocks we like better than 3SBio
- How Berkshire’s New York Times Bet Looks Today
- Affirm’s Google Deal Aims for Your Wallet
- Airplane Maintenance Companies That Keep Flights Moving Are Ready to Soar
- Oklo Stock Could Be Ready for Another Massive Run
Receive News & Ratings for 3SBio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 3SBio and related companies with MarketBeat.com's FREE daily email newsletter.
